Ethanolamine derivatives having .beta.-adrenergic blocking activ

Details Ethanolamine derivatives having .beta.-adrenergic blocking activ Ethanolamine derivatives having .beta.-adrenergic blocking activ

1975-12-29

1977-07-05

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

260 793R, 2605011, 26050119, 26050117, 260556R, 260556A, 260556AR, 260556B, A61K 3118

Patent

active

040341127

ABSTRACT:
Novel 1-aryl-2-amidoalkylaminoethanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess .beta.-adrenergic blocking activity. Representative of the compounds disclosed is 1-phenyl-2-(1,1-dimethyl-2-phenylacetamidoethyl)aminoethanol.

REFERENCES:
patent: 3816516 (1974-06-01), Cox et al.
patent: 3928412 (1975-12-01), Smith
patent: 3944611 (1976-03-01), Smith

Affiliated with

Also associated with

Rating

Ethanolamine derivatives having .beta.-adrenergic blocking activ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ethanolamine derivatives having .beta.-adrenergic blocking activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ethanolamine derivatives having .beta.-adrenergic blocking activ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-578494